← FDA Drug Approvals (Drugs@FDA)
POSACONAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SINOTHERAPEUTICS INC · Approved 2019-08-21
Drug application
- FDA Application #
ANDA212411- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POSACONAZOLE
- Generic name
- POSACONAZOLE DELAYED-RELEASE
- Active ingredients
- POSACONAZOLE
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SINOTHERAPEUTICS INC
- Manufacturer
- Chartwell RX, LLC
- First approval
- 2019-08-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown